Opinion|Videos|July 29, 2024
Decision-Making in CLL: The Role of Real-World Evidence
A discussion on therapeutic decision-making in CLL and the role of real-world evidence.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- How do you integrate real-world evidence into your clinical decision-making process for BTK inhibitors in CLL?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
2
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
3
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
4
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
5